Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons

Michael A Rogawski

doi:10.1016/0014-2999(87)90670-4

Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons

Michael A Rogawski

Research output: Contribution to journal › Article

86 Scopus citations

Abstract

Tetrahydroaminoacridine (THA) is a centrally active anticholinesterase that may produce functional improvement in patients with Alzheimer's disease. Because of its structural similarity to the potassium channel (A-current) blocking drug 4-aminopyridine (4-AP), it has been speculated that some of the therapeutic benefit of THA might result from inhibition of potassium currents. In the present study, THA produced a dose-dependent, reversible block of the A-current in cultured hippocampal neurons (IC₅₀, 30 μM). However, at similar concentrations it also inhibited other voltage-dependent currents.

Original language	English (US)
Pages (from-to)	169-172
Number of pages	4
Journal	European Journal of Pharmacology
Volume	142
Issue number	1
DOIs	https://doi.org/10.1016/0014-2999(87)90670-4
State	Published - Oct 6 1987
Externally published	Yes

Keywords

Alzheimer's disease
Hippocampus
Potassium channel
Tacrine
Tetrahydroaminoacridine
Whole cell patch clamp recording

ASJC Scopus subject areas

Cellular and Molecular Neuroscience
Pharmacology

Access to Document

10.1016/0014-2999(87)90670-4

Fingerprint Dive into the research topics of 'Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons'. Together they form a unique fingerprint.

Cite this

Rogawski, M. A. (1987). Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. European Journal of Pharmacology, 142(1), 169-172. https://doi.org/10.1016/0014-2999(87)90670-4

@article{46940ac78fed4629a5052fecdae4e1fd,

title = "Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons",

abstract = "Tetrahydroaminoacridine (THA) is a centrally active anticholinesterase that may produce functional improvement in patients with Alzheimer's disease. Because of its structural similarity to the potassium channel (A-current) blocking drug 4-aminopyridine (4-AP), it has been speculated that some of the therapeutic benefit of THA might result from inhibition of potassium currents. In the present study, THA produced a dose-dependent, reversible block of the A-current in cultured hippocampal neurons (IC50, 30 μM). However, at similar concentrations it also inhibited other voltage-dependent currents.",

keywords = "Alzheimer's disease, Hippocampus, Potassium channel, Tacrine, Tetrahydroaminoacridine, Whole cell patch clamp recording",

author = "Rogawski, {Michael A}",

year = "1987",

month = oct,

day = "6",

doi = "10.1016/0014-2999(87)90670-4",

language = "English (US)",

volume = "142",

pages = "169--172",

journal = "European Journal of Pharmacology",

issn = "0014-2999",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons

AU - Rogawski, Michael A

PY - 1987/10/6

Y1 - 1987/10/6

N2 - Tetrahydroaminoacridine (THA) is a centrally active anticholinesterase that may produce functional improvement in patients with Alzheimer's disease. Because of its structural similarity to the potassium channel (A-current) blocking drug 4-aminopyridine (4-AP), it has been speculated that some of the therapeutic benefit of THA might result from inhibition of potassium currents. In the present study, THA produced a dose-dependent, reversible block of the A-current in cultured hippocampal neurons (IC50, 30 μM). However, at similar concentrations it also inhibited other voltage-dependent currents.

AB - Tetrahydroaminoacridine (THA) is a centrally active anticholinesterase that may produce functional improvement in patients with Alzheimer's disease. Because of its structural similarity to the potassium channel (A-current) blocking drug 4-aminopyridine (4-AP), it has been speculated that some of the therapeutic benefit of THA might result from inhibition of potassium currents. In the present study, THA produced a dose-dependent, reversible block of the A-current in cultured hippocampal neurons (IC50, 30 μM). However, at similar concentrations it also inhibited other voltage-dependent currents.

KW - Alzheimer's disease

KW - Hippocampus

KW - Potassium channel

KW - Tacrine

KW - Tetrahydroaminoacridine

KW - Whole cell patch clamp recording

UR - http://www.scopus.com/inward/record.url?scp=0023229517&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023229517&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(87)90670-4

DO - 10.1016/0014-2999(87)90670-4

M3 - Article

C2 - 2446884

AN - SCOPUS:0023229517

VL - 142

SP - 169

EP - 172

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -